Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-016708
Filing Date
2024-06-13
Accepted
2024-06-13 17:30:16
Documents
1
Period of Report
2024-06-11

Document Format Files

Seq Description Document Type Size
1 form4-06132024_090610.html 4  
1 form4-06132024_090610.xml 4 5791
  Complete submission text file 0001415889-24-016708.txt   7383
Mailing Address C/O MAXCYTE, INC. 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850
Business Address
BALTHROP PATRICK J (Reporting) CIK: 0001284839 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40674 | Film No.: 241042291

Mailing Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850
Business Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850 301-517-5556
MAXCYTE, INC. (Issuer) CIK: 0001287098 (see all company filings)

EIN.: 522210438 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)